1. Medtech Insight
  2. >>Policy & Regulation

Expanding Medicare Coverage For Digital Health Technologies Gains Support

 
• By Marion Webb

AdvaMed outlined recommendations to expand Medicare coverage for digital health tech. Several lawmakers are also pushing to retain flexibilities after the COVID-19 public health emergency expires.

Telemedicine

While the COVID-19 pandemic has spurred a seismic shift in terms of adoption of digital health technologies, questions persist around whether some of the flexibilities enacted during the pandemic will become permanent.

In a 10 March webinar hosted by AdvaMed, representatives of the medtech industry advocacy group and Washington, DC, health policy consulting group CapView Strategies outlined their recommendations on how the US Centers for Medicare and Medicaid Services (CMS)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Does Makary’s Reorg Choice Mark FDA Turning Point?

 
• By Michael McCaughan

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By Elizabeth Orr

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.